Clinical Trial Update: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit [NA]

View source ↗

Summary

The document provides an update on a completed clinical performance study protocol for the Therascreen KRAS RGQ PCR Kit in non-small cell lung cancer and colore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Therascreen KRAS RGQ PCR Kit (KRAS RGQ PCR Kit)

Snippet

Sponsor: QIAGEN Gaithersburg, Inc | Conditions: Non-Small Cell Lung Cancer, Colorectal Cancer | NA | Status: COMPLETED